Literature DB >> 8470382

Controversies in measles immunization recommendations.

A S Robbins1.   

Abstract

Controversy in medicine is inevitable, but it becomes problematic when the issue is a serious public health problem requiring a clear plan of action. In recent years measles has made a major resurgence in this country, with provisional figures showing 89 measles-related deaths in 1990. The Immunization Practices Advisory Committee of the US Public Health Service, the Committee on Infectious Diseases of the American Academy of Pediatrics, and the US Preventive Services Task Force have all issued recommendations for measles immunization. Most of these recommendations are in agreement, but they conflict on the age at which vaccination should be given and the number of doses. To assist physicians in disentangling this complex web, I review the history of measles immunization in the United States and give the rationale for particular positions wherein the groups disagree. I describe protocols for routine vaccinations, endemic areas, outbreak control, colleges and universities, and international travel.

Mesh:

Substances:

Year:  1993        PMID: 8470382      PMCID: PMC1021935     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  9 in total

1.  MEASLES EXPOSURE AMONG VACCINE RECIPIENTS. RESPONSE TO MEASLES EXPOSURE AND ANTIBODY PERSISTENCE AMONG RECIPIENTS OF MEASLES VACCINES.

Authors:  V A FULGINITI; C H KEMPE
Journal:  Am J Dis Child       Date:  1963-11

2.  Use of live-measles-virus vaccine to abort an expected outbreak of measles within a closed population.

Authors:  S BERKOVICH; S STARR
Journal:  N Engl J Med       Date:  1963-07-11       Impact factor: 91.245

3.  Protection after exposure to measles by attenuated vaccine without gamma-globulin.

Authors:  G I WATSON
Journal:  Br Med J       Date:  1963-03-30

4.  The geographic distribution of measles in the United States, 1980 through 1989.

Authors:  B S Hersh; L E Markowitz; E F Maes; A W Funkhouser; A L Baughman; B I Sirotkin; S C Hadler
Journal:  JAMA       Date:  1992-04-08       Impact factor: 56.272

5.  Mumps outbreak in a highly vaccinated population.

Authors:  B S Hersh; P E Fine; W K Kent; S L Cochi; L H Kahn; E R Zell; P L Hays; C L Wood
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

Review 6.  Duration of live measles vaccine-induced immunity.

Authors:  L E Markowitz; S R Preblud; P E Fine; W A Orenstein
Journal:  Pediatr Infect Dis J       Date:  1990-02       Impact factor: 2.129

7.  Revaccination of previously vaccinated siblings of children with measles during an outbreak.

Authors:  D G Addiss; J L Berg; J P Davis
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

8.  Patterns of transmission in measles outbreaks in the United States, 1985-1986.

Authors:  L E Markowitz; S R Preblud; W A Orenstein; E Z Rovira; N C Adams; C E Hawkins; A R Hinman
Journal:  N Engl J Med       Date:  1989-01-12       Impact factor: 91.245

9.  Further-attenuated measles vaccine: characteristics and use.

Authors:  S Krugman
Journal:  Rev Infect Dis       Date:  1983 May-Jun
  9 in total
  1 in total

Review 1.  The regulation and maturation of antiviral immune responses.

Authors:  J Lindsay Whitton; Mark K Slifka; Fei Liu; Alexander K Nussbaum; Jason K Whitmire
Journal:  Adv Virus Res       Date:  2004       Impact factor: 9.937

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.